SPRB News and Press, Spruce Biosciences Inc. From 11/11/25

2025-11-11 07:07:19 ET from JMP Securities issued a price target of $259.00 for SPRB on 2025-11-11 10:52:57. The adjusted price target was set to $259.00. At the time of the announcement, SPRB was trading at $115.61. The overall price target consensus is at $207.00 with ...

2025-11-10 16:59:13 ET More on Spruce Biosciences Spruce: BTD For TA-ERT For MPS IIIB Could Ignite BLA Submission With Added Bonuses (Rating Upgrade) Spruce Biosciences raises $50M in private placement; shares down Seeking Alpha’s Quant Rating on Spruce Biosci...

Granted Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfillipo Syndrome Type B (MPS IIIB) Biologics License Application Submission of TA-ERT for the Treatment of MPS IIIB on Track for the First Quarter of 2026 Co...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-09 17:42:17 ET Spruce Biosciences, Inc. (SPRB) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 2.67%. The average open to low on the day of earnings was -6.96%. The average open ...

2025-10-28 06:15:10 ET Citigroup analyst issues OUTPERFORM recommendation for SPRB on October 28, 2025 05:54AM ET. SPRB was trading at $123.02 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, 8 -...

2025-10-21 15:07:53 ET from Leerink Partners issued a price target of $160.00 for SPRB on 2025-10-21 18:38:00. The adjusted price target was set to $160.00. At the time of the announcement, SPRB was trading at $134. SPRB currently trades -44.10% versus its 52 week high o...

2025-10-08 08:10:26 ET More on Spruce Biosciences Spruce: BTD For TA-ERT For MPS IIIB Could Ignite BLA Submission With Added Bonuses (Rating Upgrade) Seeking Alpha’s Quant Rating on Spruce Biosciences Historical earnings data for Spruce Biosciences Fin...

Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it has entered into a definitive securities purchase agreement for a pr...

A look at the top 10 most actives in the United States Nuburu Inc. (BURU) rose 86.3% to $0.475 on volume of 904,107,668 shares Connexa Sports Technologies Inc. (YYAI) fell 92.8% to $0.18 on volume of 365,683,336 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 6.6% to $4.55 on...